3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
523
Leukemia, Myeloid, Acute
499
Neoplasms
381
Carcinoma, Non-Small-Cell Lung
381
Pancreatic Neoplasms
329
Precursor Cell Lymphoblastic Leukemia-Lymphoma
319
Multiple Myeloma
312
Glioblastoma
311
Melanoma
309
Prostatic Neoplasms
293
Leukemia
289
Neoplasm Metastasis
284
Brain Neoplasms
276
Lymphoma
271
Lung Neoplasms
270
Recurrence
266
Ovarian Neoplasms
247
Colorectal Neoplasms
246
Lymphoma, Non-Hodgkin
242
Leukemia, Lymphocytic, Chronic, B-Cell
231
Myelodysplastic Syndromes
208
Glioma
208
Lymphoma, Large B-Cell, Diffuse
186
Carcinoma, Hepatocellular
173
Lymphoma, Follicular
167
Head and Neck Neoplasms
162
Hodgkin Disease
160
Lymphoma, Mantle-Cell
155
Burkitt Lymphoma
154
Sarcoma
150
Interventions
epitumomab
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
OTHER
×
Anophthalmia with pulmonary hypoplasia
×
Clear all
NCT02132403
2015-05-01
PM-01
University of Illinois at Chicago
Phase 1
Terminated
3 enrolled